ID   ARF1_RAT                Reviewed;         181 AA.
AC   P84079; P10947; P32889;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   02-OCT-2024, entry version 168.
DE   RecName: Full=ADP-ribosylation factor 1;
DE            EC=3.6.5.2 {ECO:0000250|UniProtKB:P84077};
GN   Name=Arf1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8813705; DOI=10.1007/bf00226058;
RA   Price S.R., Nightingale M.S., Tsuchiya M., Moss J., Vaughan M.;
RT   "Interspecies relationships among ADP-ribosylation factors (ARFs): evidence
RT   of evolutionary pressure to maintain individual identities.";
RL   Mol. Cell. Biochem. 159:15-23(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pituitary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   INTERACTION WITH ARFGAP1.
RX   PubMed=7890632; DOI=10.1074/jbc.270.10.5232;
RA   Makler V., Cukierman E., Rotman M., Admon A., Cassel D.;
RT   "ADP-ribosylation factor-directed GTPase-activating protein. Purification
RT   and partial characterization.";
RL   J. Biol. Chem. 270:5232-5237(1995).
RN   [4]
RP   INTERACTION WITH PRKCABP.
RX   PubMed=10623590; DOI=10.1006/bbrc.1999.1932;
RA   Takeya R., Takeshige K., Sumimoto H.;
RT   "Interaction of the PDZ domain of human PICK1 with class I ADP-ribosylation
RT   factors.";
RL   Biochem. Biophys. Res. Commun. 267:149-155(2000).
RN   [5]
RP   INTERACTION WITH ASAP2.
RX   PubMed=10022920; DOI=10.1128/mcb.19.3.2338;
RA   Andreev J., Simon J.-P., Sabatini D.D., Kam J., Plowman G., Randazzo P.A.,
RA   Schlessinger J.;
RT   "Identification of a new Pyk2 target protein with Arf-GAP activity.";
RL   Mol. Cell. Biol. 19:2338-2350(1999).
RN   [6]
RP   INTERACTION WITH PIP5K1B.
RX   PubMed=10747863; DOI=10.1074/jbc.c901019199;
RA   Jones D.H., Morris J.B., Morgan C.P., Kondo H., Irvine R.F., Cockcroft S.;
RT   "Type I phosphatidylinositol 4-phosphate 5-kinase directly interacts with
RT   ADP-ribosylation factor 1 and is responsible for phosphatidylinositol 4,5-
RT   bisphosphate synthesis in the Golgi compartment.";
RL   J. Biol. Chem. 275:13962-13966(2000).
RN   [7]
RP   FUNCTION, INTERACTION WITH PICK1 AND GRIA2, AND SUBCELLULAR LOCATION.
RX   PubMed=23889934; DOI=10.1016/j.neuron.2013.05.003;
RA   Rocca D.L., Amici M., Antoniou A., Suarez E.B., Halemani N., Murk K.,
RA   McGarvey J., Jaafari N., Mellor J.R., Collingridge G.L., Hanley J.G.;
RT   "The small GTPase Arf1 modulates Arp2/3-mediated actin polymerization via
RT   PICK1 to regulate synaptic plasticity.";
RL   Neuron 79:293-307(2013).
RN   [8] {ECO:0007744|PDB:1RRF, ECO:0007744|PDB:1RRG}
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) IN COMPLEX WITH GDP.
RX   PubMed=7552752; DOI=10.1038/nsb0995-797;
RA   Greasley S.E., Jhoti H., Teahan C., Solari R., Fensome A., Thomas G.M.,
RA   Cockcroft S., Bax B.;
RT   "The structure of rat ADP-ribosylation factor-1 (ARF-1) complexed to GDP
RT   determined from two different crystal forms.";
RL   Nat. Struct. Biol. 2:797-806(1995).
CC   -!- FUNCTION: Small GTPase involved in protein trafficking between
CC       different compartments (By similarity). Modulates vesicle budding and
CC       uncoating within the Golgi complex (By similarity). In its GTP-bound
CC       form, triggers the recruitment of coatomer proteins to the Golgi
CC       membrane (By similarity). The hydrolysis of ARF1-bound GTP, which is
CC       mediated by ARFGAPs proteins, is required for dissociation of coat
CC       proteins from Golgi membranes and vesicles (By similarity). The GTP-
CC       bound form interacts with PICK1 to limit PICK1-mediated inhibition of
CC       Arp2/3 complex activity; the function is linked to AMPA receptor
CC       (AMPAR) trafficking, regulation of synaptic plasticity of excitatory
CC       synapses and spine shrinkage during long-term depression (LTD)
CC       (PubMed:23889934). Plays a key role in the regulation of intestinal
CC       stem cells and gut microbiota, and is essential for maintaining
CC       intestinal homeostasis (By similarity). Plays also a critical role in
CC       mast cell expansion but not in mast cell maturation by facilitating
CC       optimal mTORC1 activation (By similarity).
CC       {ECO:0000250|UniProtKB:P84077, ECO:0000269|PubMed:23889934}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP + H2O = GDP + H(+) + phosphate; Xref=Rhea:RHEA:19669,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58189; EC=3.6.5.2;
CC         Evidence={ECO:0000250|UniProtKB:P84077};
CC   -!- ACTIVITY REGULATION: Alternates between an inactive GDP-bound form and
CC       an active GTP-bound form (By similarity). Activated by guanine
CC       nucleotide-exchange factors (GEFs) and inactivated by GTPase-activating
CC       proteins (GAPs) (By similarity). {ECO:0000250|UniProtKB:P84077}.
CC   -!- SUBUNIT: Interacts (when activated) with GGA1, GGA2 and GGA3; the
CC       interaction is required for proper subcellular location of GGA1, GGA2
CC       and GGA3 (By similarity). Interacts with ARHGAP21, ASAP2, HERC1,
CC       PRKCABP, PIP5K1B, TMED2, PSCD2, TMED10 and GRIA2 (PubMed:10022920,
CC       PubMed:10623590, PubMed:10747863, PubMed:23889934). Interacts with
CC       ARFGAP1, which hydrolyzes GTP and thus, regulates its function
CC       (PubMed:7890632). Interacts with PI4KB in the Golgi complex. Interacts
CC       with NCS1/FREQ in the Golgi and at the plasma membrane. Interacts with
CC       PLEKHA3. Interacts with PLEKHA8; the interaction, together with
CC       phosphatidylinositol 4-phosphate binding, is required for FAPP2-
CC       mediated glucosylceramide transfer activity (By similarity). Interacts
CC       (activated) with PICK1 (via PDZ domain); the interaction blocks Arp2/3
CC       complex inhibition (PubMed:23889934). Interacts with IQSEC1 (By
CC       similarity). Interacts with C9orf72 (By similarity).
CC       {ECO:0000250|UniProtKB:P84077, ECO:0000250|UniProtKB:P84078,
CC       ECO:0000269|PubMed:10022920, ECO:0000269|PubMed:10623590,
CC       ECO:0000269|PubMed:10747863, ECO:0000269|PubMed:23889934,
CC       ECO:0000269|PubMed:7890632}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:23889934}; Lipid-anchor
CC       {ECO:0000250|UniProtKB:P84080}; Cytoplasmic side {ECO:0000305}.
CC       Synapse, synaptosome {ECO:0000269|PubMed:23889934}. Postsynaptic
CC       density {ECO:0000269|PubMed:23889934}. Note=In the GDP-bound form,
CC       associates transiently with the membranes via its myristoylated N-
CC       terminus where guanine nucleotide-exchange factor (GEF)-mediated
CC       nucleotide exchange occurs (By similarity). Following nucleotide
CC       exchange, the GTP-bound form undergoes a conformational change, leading
CC       to the exposure of a myristoylated N-terminal amphipathic helix that
CC       provides stable membrane anchorage (By similarity).
CC       {ECO:0000250|UniProtKB:P84080}.
CC   -!- SIMILARITY: Belongs to the small GTPase superfamily. Arf family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L12380; AAA40685.1; -; mRNA.
DR   EMBL; BC061552; AAH61552.1; -; mRNA.
DR   RefSeq; NP_071963.1; NM_022518.3.
DR   RefSeq; XP_006246587.1; XM_006246525.3.
DR   PDB; 1RRF; X-ray; 3.00 A; A=1-181.
DR   PDB; 1RRG; X-ray; 2.40 A; A/B=1-181.
DR   PDBsum; 1RRF; -.
DR   PDBsum; 1RRG; -.
DR   AlphaFoldDB; P84079; -.
DR   BMRB; P84079; -.
DR   SMR; P84079; -.
DR   BioGRID; 249023; 1.
DR   CORUM; P84079; -.
DR   IntAct; P84079; 2.
DR   STRING; 10116.ENSRNOP00000072575; -.
DR   iPTMnet; P84079; -.
DR   PhosphoSitePlus; P84079; -.
DR   SwissPalm; P84079; -.
DR   jPOST; P84079; -.
DR   PaxDb; 10116-ENSRNOP00000064960; -.
DR   Ensembl; ENSRNOT00000080028.2; ENSRNOP00000072575.1; ENSRNOG00000060229.2.
DR   Ensembl; ENSRNOT00055051399; ENSRNOP00055042364; ENSRNOG00055029680.
DR   Ensembl; ENSRNOT00060053692; ENSRNOP00060044568; ENSRNOG00060030926.
DR   Ensembl; ENSRNOT00065012012; ENSRNOP00065008774; ENSRNOG00065007676.
DR   GeneID; 64310; -.
DR   KEGG; rno:64310; -.
DR   UCSC; RGD:621270; rat.
DR   AGR; RGD:621270; -.
DR   CTD; 375; -.
DR   RGD; 621270; Arf1.
DR   eggNOG; KOG0070; Eukaryota.
DR   GeneTree; ENSGT00950000183080; -.
DR   HOGENOM; CLU_040729_9_3_1; -.
DR   InParanoid; P84079; -.
DR   OMA; LAFSRIW; -.
DR   OrthoDB; 5474610at2759; -.
DR   PhylomeDB; P84079; -.
DR   TreeFam; TF300808; -.
DR   Reactome; R-RNO-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-RNO-1660514; Synthesis of PIPs at the Golgi membrane.
DR   Reactome; R-RNO-199992; trans-Golgi Network Vesicle Budding.
DR   Reactome; R-RNO-2132295; MHC class II antigen presentation.
DR   Reactome; R-RNO-432720; Lysosome Vesicle Biogenesis.
DR   Reactome; R-RNO-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-RNO-6807878; COPI-mediated anterograde transport.
DR   Reactome; R-RNO-6811434; COPI-dependent Golgi-to-ER retrograde traffic.
DR   Reactome; R-RNO-6811438; Intra-Golgi traffic.
DR   Reactome; R-RNO-9845576; Glycosphingolipid transport.
DR   EvolutionaryTrace; P84079; -.
DR   PRO; PR:P84079; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000060229; Expressed in jejunum and 19 other cell types or tissues.
DR   GO; GO:0031252; C:cell leading edge; ISO:RGD.
DR   GO; GO:0030137; C:COPI-coated vesicle; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0012505; C:endomembrane system; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0000139; C:Golgi membrane; IDA:RGD.
DR   GO; GO:0005770; C:late endosome; IDA:RGD.
DR   GO; GO:0043005; C:neuron projection; IEA:UniProtKB-KW.
DR   GO; GO:0005778; C:peroxisomal membrane; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0030017; C:sarcomere; ISO:RGD.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:RGD.
DR   GO; GO:0019003; F:GDP binding; IDA:RGD.
DR   GO; GO:0005525; F:GTP binding; IDA:RGD.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:RGD.
DR   GO; GO:1990583; F:phospholipase D activator activity; IDA:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0007015; P:actin filament organization; IMP:RGD.
DR   GO; GO:0097061; P:dendritic spine organization; IMP:UniProtKB.
DR   GO; GO:0055108; P:Golgi to transport vesicle transport; IDA:RGD.
DR   GO; GO:0006878; P:intracellular copper ion homeostasis; ISO:RGD.
DR   GO; GO:0006886; P:intracellular protein transport; IBA:GO_Central.
DR   GO; GO:0060292; P:long-term synaptic depression; IDA:UniProtKB.
DR   GO; GO:0097212; P:lysosomal membrane organization; IDA:RGD.
DR   GO; GO:1990386; P:mitotic cleavage furrow ingression; ISO:RGD.
DR   GO; GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IDA:RGD.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; IMP:RGD.
DR   GO; GO:0045807; P:positive regulation of endocytosis; IMP:RGD.
DR   GO; GO:1902953; P:positive regulation of ER to Golgi vesicle-mediated transport; IMP:RGD.
DR   GO; GO:1902824; P:positive regulation of late endosome to lysosome transport; IMP:RGD.
DR   GO; GO:0050714; P:positive regulation of protein secretion; IMP:RGD.
DR   GO; GO:1902307; P:positive regulation of sodium ion transmembrane transport; IMP:RGD.
DR   GO; GO:0098974; P:postsynaptic actin cytoskeleton organization; IDA:SynGO.
DR   GO; GO:0034315; P:regulation of Arp2/3 complex-mediated actin nucleation; IDA:UniProtKB.
DR   GO; GO:1903725; P:regulation of phospholipid metabolic process; IDA:RGD.
DR   GO; GO:0002090; P:regulation of receptor internalization; IDA:UniProtKB.
DR   GO; GO:0070142; P:synaptic vesicle budding; IMP:RGD.
DR   GO; GO:0034379; P:very-low-density lipoprotein particle assembly; IMP:RGD.
DR   GO; GO:0016192; P:vesicle-mediated transport; ISO:RGD.
DR   CDD; cd04150; Arf1_5_like; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR045872; Arf1-5-like.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR005225; Small_GTP-bd_dom.
DR   InterPro; IPR024156; Small_GTPase_ARF.
DR   InterPro; IPR006689; Small_GTPase_ARF/SAR.
DR   NCBIfam; TIGR00231; small_GTP; 1.
DR   PANTHER; PTHR11711; ADP RIBOSYLATION FACTOR-RELATED; 1.
DR   PANTHER; PTHR11711:SF357; ADP-RIBOSYLATION FACTOR 1; 1.
DR   Pfam; PF00025; Arf; 1.
DR   PRINTS; PR00328; SAR1GTPBP.
DR   SMART; SM00177; ARF; 1.
DR   SMART; SM00175; RAB; 1.
DR   SMART; SM00178; SAR; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS51417; ARF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ER-Golgi transport; Golgi apparatus;
KW   GTP-binding; Hydrolase; Lipoprotein; Membrane; Myristate;
KW   Nucleotide-binding; Protein transport; Reference proteome; Synapse;
KW   Synaptosome; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P84077"
FT   CHAIN           2..181
FT                   /note="ADP-ribosylation factor 1"
FT                   /id="PRO_0000207381"
FT   REGION          3..16
FT                   /note="Important for the stable binding to the membranes"
FT                   /evidence="ECO:0000250|UniProtKB:P84080"
FT   BINDING         24..32
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:7552752,
FT                   ECO:0007744|PDB:1RRF, ECO:0007744|PDB:1RRG"
FT   BINDING         126..129
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:7552752,
FT                   ECO:0007744|PDB:1RRF, ECO:0007744|PDB:1RRG"
FT   BINDING         160
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:7552752,
FT                   ECO:0007744|PDB:1RRG"
FT   MOD_RES         2
FT                   /note="N-acetylglycine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84077"
FT   LIPID           2
FT                   /note="N-myristoyl glycine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84077"
FT   HELIX           3..10
FT                   /evidence="ECO:0007829|PDB:1RRG"
FT   STRAND          14..16
FT                   /evidence="ECO:0007829|PDB:1RRG"
FT   STRAND          18..25
FT                   /evidence="ECO:0007829|PDB:1RRG"
FT   HELIX           30..37
FT                   /evidence="ECO:0007829|PDB:1RRG"
FT   STRAND          42..48
FT                   /evidence="ECO:0007829|PDB:1RRG"
FT   STRAND          51..57
FT                   /evidence="ECO:0007829|PDB:1RRG"
FT   STRAND          59..67
FT                   /evidence="ECO:0007829|PDB:1RRG"
FT   HELIX           77..82
FT                   /evidence="ECO:0007829|PDB:1RRG"
FT   STRAND          85..93
FT                   /evidence="ECO:0007829|PDB:1RRG"
FT   HELIX           100..111
FT                   /evidence="ECO:0007829|PDB:1RRG"
FT   HELIX           114..116
FT                   /evidence="ECO:0007829|PDB:1RRG"
FT   STRAND          120..126
FT                   /evidence="ECO:0007829|PDB:1RRG"
FT   STRAND          130..132
FT                   /evidence="ECO:0007829|PDB:1RRF"
FT   HELIX           136..142
FT                   /evidence="ECO:0007829|PDB:1RRG"
FT   HELIX           145..147
FT                   /evidence="ECO:0007829|PDB:1RRG"
FT   STRAND          155..157
FT                   /evidence="ECO:0007829|PDB:1RRG"
FT   TURN            160..162
FT                   /evidence="ECO:0007829|PDB:1RRG"
FT   HELIX           166..178
FT                   /evidence="ECO:0007829|PDB:1RRG"
SQ   SEQUENCE   181 AA;  20697 MW;  AAC773D4A60186B6 CRC64;
     MGNIFANLFK GLFGKKEMRI LMVGLDAAGK TTILYKLKLG EIVTTIPTIG FNVETVEYKN
     ISFTVWDVGG QDKIRPLWRH YFQNTQGLIF VVDSNDRERV NEAREELMRM LAEDELRDAV
     LLVFANKQDL PNAMNAAEIT DKLGLHSLRH RNWYIQATCA TSGDGLYEGL DWLSNQLRNQ
     K
//
